Newsroom

Felix Deschner in the lab
News
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel mode of action are urgently needed. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now uncovered the mode of action of a promising class of natural products – the chlorotonils. These molecules simultaneously target the bacterial cell membrane and the bacteria’s ability to produce proteins, enabling them to break through resistance. The team published its findings in the journal Cell Chemical Biology.
15.04.2025
Future Day
News
Today, around 60 schoolchildren from grades 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to gain an insight into the work of a modern research institution. They were able to immerse themselves in the fascinating world of science in a total of eight different departments.
03.04.2025
Group image
News
On March 17 and 18, 2025, the kick-off meeting of the INFRALINK network took place at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Six partner institutions will establish a network to facilitate infection research between the public health service and research institutions. The project is being funded by the Volkswagen Foundation with 500,000 euros.
02.04.2025
Josef Penninger
News
Science is currently facing major challenges in the United States – and with noticeable impacts on Europe. Research budgets have been and continue to be cut and jobs lost, even in key areas such as health and infectious diseases. A viewpoint from Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research.
01.04.2025
Electron microscope image
News
An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin – a key trigger of tissue damage and inflammation.
01.04.2025
Florian Hubrich and Mariia Nesterkina
News
Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom to implement new and possibly riskier project ideas. One funding instrument that focuses on supporting early stage researchers is the Klaus-Tschira-Boost-Fund. In the current round of applications, 15 out of more than 300 applicants were selected to receive funding of up to 120,000 Euros each – amongst them the junior researchers Mariia Nesterkina and Florian Hubrich from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. As so-called “Boost Fellows”, Mariia Nesterkina and Florian Hubrich benefit not only from the funding itself, but also from a series of workshops on career development and gain access to extensive career counseling and coaching services. The funded projects are set to start between April and October 2025 and will run for 24 months.
01.04.2025

HZI in the media

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025
|
AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025
|
Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025
|
Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025
|
Apotheken Umschau

... am 1. Oktober 2025. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

07.10.2025
|
juraforum.de

... „Epidemiologie und Ökologie antimikrobieller Resistenz“ am HZI-Standort Helmholtz-Institut für One Health (HIOH), am Projekt ...

06.10.2025
|
Bochumer-Zeitung

” says Mark Brönstrup, a professor at both the Helmholtz Center for Infection Research and Leibniz University Hannover, who wasn’t involved

04.10.2025
|
MIT CSAIL

... Hannover (MHH) und Klinischer Direktor des Helmholtz-Zentrums für Infektionsforschung (HZI). Auch an der Gründung des ...

03.10.2025
|
Deutsches Ärzteblatt

... des Sensormoleküls

 

Prof. Carlos A. Guzmán (Helmholtz-Zentrum für Infektionsforschung, Braunschweig) mit den Teams um Dr. ...

02.10.2025
|
Medizin Aspekte

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025
|
Die heutigen Nachrichten

Register now for the HZI-Newsletter